Sugar Derivatives TRIZ Cases

A third proximity probe acts as a binding splint to mediate ligation between analyte-bound probes.

Neutral pH chemoenzymatic methods synthesize stable N-acyl sialic acids, preserving the labile 9-O-acetyl group lost under standard acidic or basic conditions.

Antibodies targeting human collagen II retain therapeutic agents locally, reducing systemic side effects from short half-life treatments.

FLT3-functionalized PAMAM dendrimers deliver miR-22 to AML cells, overcoming poor survival rates from ineffective conventional chemotherapies.

Pyrophosphorolysis activated polymerization detects single copy donor-positive recipient-negative DNA markers, resolving PCR false positive rates.

Sugar groups attached to the diarylethene core provide hydrophilicity, resolving aggregation issues in aqueous environments for super-resolution microscopy.

Replacing the 3-carboxy group with an amido structure prevents side reactions and aggregation, improving conjugation efficiency in biological samples.

Self-immolative linkers enable controlled antigen release, resolving T-cell anergy and improving immune response reliability.

Modifying streptavidin residues alters dissociation constants to allow mild biotin elution without protein damage.

Segmented membrane filtration removes oligosaccharide impurities without organic solvents, lowering production costs for food-grade purification.

A template switching oligonucleotide hybridizes to the 3' end of target nucleic acids to enable polymerase extension.

Carrier-mediated delivery of chemically modified dsRNA activates TLR-3 and RLR receptors in non-immune cells, resolving limited cellular uptake.

Genetically modified rodents expressing human PD-L1 proteins create accurate in vivo models for antibody drug evaluation.

Formula I compounds reduce viral reservoirs and minimize drug resistance, addressing limitations of current antiretroviral therapies.

A boronic acid and alpha-effect amine reaction forming stable hydrazono adducts at neutral pH without toxic catalysts.

Linking molecules bridge nucleic acid targets and capture probes to form stable binding complexes.

Preliminary molecular characterization of NPHP6 enables targeted detection assays that resolve the trade-off between diagnostic precision and assay complexity.

Hydroxyl free radicals cleave cellulose polymer chains to reduce molecular weight, eliminating energy-intensive mechanical grinding.

Single-stranded polynucleotide tags hybridize to destabilized target regions, resolving non-specific capture issues in large fragment isolation.

Combining ADTT with aromatic heterocyclic and hydrocarbon compounds stabilizes the thiolation solution, preventing decomposition during nucleic acid synthesis.

Oligonucleotide probes target GBS genes, replacing slow culture methods with direct DNA detection to accelerate clinical diagnosis.

Optimized ceramic hydroxyapatite chromatography removes dsRNA impurities to enhance mRNA treatment efficacy and minimize immune responses.

Alkyl quinolone biomarkers resolve the contradiction between early detection sensitivity and false positive rates in Pseudomonas aeruginosa diagnosis.

Cleavable linkers allow sequential labeling and unlabeling cycles, resolving the trade-off between stable conjugation reliability and multi-analyte versatility.

Stereochemical control and chemical modifications increase PNPLA3 oligonucleotide stability against nuclease degradation.

Modified alpha-galactosylceramides inhibit inflammatory cytokine release by blocking activation of invariant natural killer T cells.

Plant-derived transcription terminators terminate RNA polymerase activity to prevent gene silencing and simplify regulatory approval.

Structural modifications of flavone cores with hydrophilic groups reduce toxicity while enhancing antitumor activity and bioavailability.

Diarylsulfide chromophores shift photolabile protecting group absorption to visible light, replacing hazardous near-UV sources and lowering operational costs.

DNA-encoded probes link enzymatic activity to amplifiable barcodes, replacing complex instrumentation with cost-effective sequencing.

Segmenting diagnostic workflows with focused gene panels resolves specificity contradictions in thyroid cancer classification.

Detecting single-molecule DNA sequences through physical blockage of renaturation, eliminating PCR time and contamination risks.

Recombinant chimeric proteins delete specific B epitopes to eliminate adverse reactions and maintain immune tolerance induction.

The pNEW system replaces toxic IPTG with non-toxic cumate to resolve industrial production costs while maintaining high protein yields.

Diagnostic microRNAs determine adverse prostate cancer pathology likelihood through quantitative real-time PCR analysis of biological samples.

Recombinant DNA constructs encode single-stranded RNA that binds target transcripts to form hybridized segments.

5′ position modifications enhance nuclease stability in antisense oligomers, resolving synthesis complexity while maintaining RNA targeting.

Multitype HPV L2 peptide compositions induce broad cross-neutralizing immune responses, overcoming limited protection of single-type vaccines.

R268H substitutions in Yap1-Yap8 proteins boost butanol productivity by resolving alcohol inhibition stress.

Enolic glucoside of phenylpyruvic acid acts as a GPR119 agonist to stimulate glucose-dependent insulin secretion.

Multiplex DNA primers amplify capsule locus sequences to identify 23 serotypes without expensive antisera or phase variation errors.

Triple-methylated ribose modifications prevent reverse orientation isomers, enhancing translation efficiency.

A galactose cluster-pharmacokinetic modulator conjugate directs RNA interference polynucleotides to hepatocytes via receptor-mediated endocytosis.

Natural deep eutectic solvents extract organic compounds from biological sources while eliminating toxicity and volatility hazards.

Engineered cold-adapted xylanases maintain reaction rates at 20-30°C, eliminating energy costs and product denaturation associated with thermoactive enzymes.

A diagnostic method identifies bacterial and viral infections using polypeptide concentration measurements.

Targeted C-terminal mutations in cis-aconitate decarboxylase resolve low wild-type activity limits, increasing itaconic acid yield.

Segmenting GAG lyase activities into distinct enzymes allows precise structural characterization of heterogeneous glycosaminoglycan populations.